Drug Testing Market Share, Size, Analysis, Report- By Product Type (Immunoassays Analyzers, Urine Testing Devices, Oral Fluid Testing Devices, Chromatographic Devices, Breath Analyzers) By Sample Type (Saliva, Hair, Urine, Sweat, Blood, Others),By End User (Employer, Hospitals, School & Universities, Diagnostic Laboratories, Forensic Laboratories, Others) By Market Location (North America, Europe, Asia Pacific, Latin America, Middle East and Africa- Growth & Opportunity Trends

DFS020429  | 
: Life Sciences & Healthcare  | 
Dec-2024  | 
Upcoming  | 
Pages: NA  | 
Tables: NA  | 
Figures: NA
We’ve been tracking the direct impact of COVID-19 on this market, as well as the indirect impact from other industries. The report will incorporate these insights.

Drug Testing Market was valued at USD 45 billion by 2020, growing with 8.6% CAGR during the forecast period, 2021-2030.

To keep up with the constant growth in novel drugs being misused, alternate matrices, and market demands, commercial methods for drug abuse testing have experienced significant modification in recent years. A drug test is a non-invasive technological analysis of biological materials such as blood, hair, urine, and others to detect the presence of illicit, prescribed, or metabolites of drugs. Urine testing is the most often utilized sample type for drug misuse testing. Drug testing is an important component to clinical care and substance usage. Drug testing is rapidly being utilized by sports groups, companies, forensic investigators, and a variety of other organizations.According to the UNO’s World Drug Report, an estimated 192 million people used cannabis in 2018, making it the most used drug globally. This group of substances drug testing accounted for 66% of the estimated 167,000 deaths related to drug use disorders in 2017.

Market Dynamics and Factors:

The use of narcotics has been linked to a slew of criminal acts that deplete a country's resources. These factors have prompted governments in both developed and developing countries to take legal action against addicts and abusers. In both developed and developing nations, drug usage is higher in cities than in rural regions. The huge migration of people from the countryside to towns and cities more than half of the world's population now lives in cities, up from 34% in 1960 – helps to explain the general growth in drug usage. Urbanization has the potential to be a critical factor in the future dynamics of drug markets, particularly in developing nations where urbanization is on the rise. As a result, industrialized countries such as the United States have strict drug-abuse laws and require alcohol and drug testing. To reduce violence or accidents, drug and alcohol testing on the roads, while driving, is becoming more prevalent in both emerging and developed nations, which is assisting the overall drug testing market's growth.

Fingerprint-based drug testing is a novel idea that has gained popularity as a result of the COVID-19 epidemic. Because of the potential of transmission, the coronavirus has made it impossible to conduct drug testing in hospitals, labs, and other institutions. In this case, fingerprint-based drug screening can help restrict the spread of COVID since it is non-invasive, less time-consuming, and sanitary, allows for social distance, is portable, user-friendly, and does not require any special preparation for sample collection and processing. This test is simple to administer whenever and wherever it is needed, making it ideal for flexible and effective workplace drug testing. To identify drugs and drug metabolites, the test examines tiny amounts of perspiration in the fingerprint. If extensively used, this test is likely to replace urine, hair, and blood-based drug testing. This is a huge potential for industry participants in the drug testing business to capitalize on.

Market Segmentation:

Global drug testing market share can be segmented on the basis ofByProduct Type (Immunoassays Analyzers, Urine Testing Devices, Oral Fluid Testing Devices, Chromatographic Devices, Breath Analyzers), By Sample Type (Saliva, Hair, Urine, Sweat, Blood, Others),By End User (Employer, Hospitals, School & Universities, Diagnostic Laboratories, Forensic Laboratories, Others) By Market Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa).

Geographic Analysis:

Due to the growth of numerous drug testing centres, the United States will account for the highest market share throughout the projection period. Improvements to the infrastructure and services supplied by these facilities are among the advances. For example, Drug Testing Centre of America has concentrated its efforts on providing the highest quality and most cost-effective drug testing services, therefore contributing to the industry's growth. China and India are projected to be Asia's fastest developing markets for Drug Testing technology.

Competitive Scenario:

The drug testing market share, which is highly competitive, consists of a few major players. The key players of drug testing market are Drägerwerk AG & Co. KGaA, Mayo Clinic Laboratories, Precision Diagnostics , Andatech Pty. Ltd., BACtrack, Quest Products, Inc., Alere (Abbott.), C4 Development Ltd , Quest Diagnostics., Clinical Reference Laboratory Inc. , Laboratory Corporation of America Holdings, Cordant Health Solutions, Legacy Medical Services ,Lion Laboratories Limited, Lifeloc Technologies Inc., American Substance Abuse Professionals Inc., and United States Drug Testing Laboratories Inc.

Drug Testing Market Report Scope

Report Attribute

Details

Analysis Period

2020–2030

Base Year

2021

Forecast Period

2022–2030

Market Size Estimation

Billion (USD)

Growth Rate (CAGR%)

8.6 %

Market Segmentation:

By Product Type (Immunoassays Analyzers, Urine Testing Devices, Oral Fluid Testing Devices, Chromatographic Devices, Breath Analyzers) By Sample Type (Saliva, Hair, Urine,  Sweat, Blood, Others),By End User (Employer, Hospitals, School & Universities, Diagnostic Laboratories, Forensic Laboratories, Others)

Geographical Segmentation

North America (U.S., Canada, Mexico) Europe (UK, Germany, Italy, France, Rest of Europe), Asia-Pacific (China, Japan, India, Australia, Rest of APAC), South America (Brazil, Argentina, Rest of SA), MEA (UAE, Saudi Arabia, South Africa)

Key Companies Profiled

Drägerwerk AG & Co. KGaA, Mayo Clinic Laboratories, Precision Diagnostics , Andatech Pty. Ltd., BACtrack, Quest Products, Inc., Alere (Abbott.), C4 Development Ltd , Quest Diagnostics., Clinical Reference Laboratory Inc. , Laboratory Corporation of America Holdings, Cordant Health Solutions, Legacy Medical Services ,Lion Laboratories Limited, Lifeloc Technologies Inc., American Substance Abuse Professionals Inc., and United States Drug Testing Laboratories Inc.


TOC REQUEST


KEY MARKET SEGMENTS:

By Product Type

    • Immunoassays Analyzers
    • Urine Testing Devices
    • Oral Fluid Testing Devices
    • Chromatographic Devices
    • Breath Analyzers

By Sample Type

    • Saliva
    • Hair
    • Urine
    • Sweat
    • Blood
    • Others

By End User

    • Employer
    • Hospitals
    • School & Universities
    • Diagnostic Laboratories
    • Forensic Laboratories
    • Others

By Technique

    • Centrifugation- based cell isolation
    • Surface marker- based cell isolation
    • Filtration- based cell isolation

 

  • Global Drug Testing Market – By Geography
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • U.K.
      • France
      • Germany
      • Italy
      • Rest of Europe
    • Asia-Pacific
      • Japan
      • China
      • India
      • Australia
      • Rest of Asia Pacific
    • ROW
      • Latin America
      • Middle East
      • Africa

Key Market Players


o    Drägerwerk AG & Co. KGaA
o    Mayo Clinic Laboratories
o    Precision Diagnostics 
o    Andatech Pty. Ltd.
o    BACtrack
o    Quest Products, Inc.
o    Alere (Abbott.)
o    C4 Development Ltd 
o    Quest Diagnostics.
o    Clinical Reference Laboratory Inc. 
o    Laboratory Corporation of America Holdings
o    Cordant Health Solutions
o    Legacy Medical Services 
o    Lion Laboratories Limited
o    Lifeloc Technologies Inc.
o    American Substance Abuse Professionals Inc.
o    United States Drug Testing Laboratories Inc


 
©2024 Decision Foresight. All Rights Reserved.